The activating effects of EGF and VEGF-A on downstream genes including PLAU/R highlights the potential for anti-EGFR- and/or anti-VEGF- with anti-uPA/uPAR-targeting approaches for metastatic cSCC. Here, EGFR is linked to skin squamous cell carcinoma.